AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04
International Urology Cancer Summit and OncoDaily Announce Strategic Partnership
Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy
DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC
Vivek Subbiah: Rethinking the Unified Cancer of Unknown Primary Concept
AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC
Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research
10 Must-Read Posts In GU Oncology This Week
The CAN Monthly Membership Meeting Call, organized by the Community Oncology Alliance Administrators’ Network (CAN), will take place on August 27, 2026, from 11:00 AM to 12:00 PM. The monthly call is intended for CAN members and provides a forum for community oncology practice administrators and management team members to discuss issues affecting practice operations, […]
